Thanks, operator and welcome everyone. Our first quarter results again demonstrate the versatility and resiliency of our platform. During the first quarter, we generated total revenues of $432 million, including operating revenues of $380 million and $80 million of operating EBITDA. To deliver these results in a period with minimal contribution from our episodic businesses, which historically served as our largest profit drivers, only validates our strategy. This was not by accident. We appreciate the markets we serve are volatile. Over the past 5 years, we undertook several initiatives to further enhance and diversify our platform and generate an excessive amount of cash to fund our business model. We made a series of strategic acquisitions and expanded our sources of steady and recurring earnings to further insulate our business from any downturn in capital markets like the one we are seeing today. The benefits of this strategy were highlighted by a quarter and by the fact despite the lack of large banking and retail liquidation deals during the quarter, we continue to generate enough free operating cash flow to cover our dividend, our overhead, our tax and our interest requirements. This strategy allows us to play offense while others are contracting. For example, in Q4, we made a large push to expand our middle-market health care service practice, which is already beginning to bear fruit. In February, we brought on a team of about 45 professionals from Farber to complement our advisory services. And we recently announced several senior level hires in consumer and have also boosted our TMT business with multiple senior hires that will be announced shortly. Tom will expand on this a little bit more, but this is taking place across all our businesses, and we continue to invest to grow our talent base in line with client demand. As we look at our strategic equity investments, the equity markets continue to prove challenging. In contrast, our loan book is benefiting from stressed environment for lenders and creates a multitude of opportunities for us. As it relates to our balance sheet over the last 1.5 years, we have shifted a meaningful amount of our investments into our loan book, and we believe that this is not only opportunistic but also benefits our clients in a number of ways. A recent example of this strategy is Hero Health. We provided Hero with $60 million in debt financing in January to support an acquisition and previously helped the company raise $65 million as lead bat book letter and its equity and not its offering in December. This fully backstop commitment of $125 million helped to finance this acquisition, and our loan was repaid in full in March. This is just one example of how we’ve utilized our balance sheet to partner with our clients and enable their continued success. As we mentioned last quarter, we are providing a little more detail on our loan portfolio, which you will see in our quarterly supplement. At the end of 2022, we had 12 companies in our loan portfolio, which was fair valued at approximately $380 million. This excludes our Adcock Furniture receivables portfolio and a few smaller loans at less than $1 million at fair value. Since year end, 2 of those 12 positions were closed out and repaid in full. We invested an additional $112 million across 5 new loans during the quarter, of which $65 million was repaid within the quarter. At quarter end, our loan portfolio was valued at approximately $448 million across 14 companies with an average loan size of approximately $34 million. Our combined bank cot furniture receivables portfolio was valued at approximately $320 million at year-end, of which we expect 8% to be paid down every month. During the quarter, we made an additional investment in our receivables portfolio. We continue to see performance in line with our underwriting with 25 plus rates of return. Regarding our unleveled purchase of the first portfolio, as of March, we have recouped our initial investment of $400 million and today have an incremental $112 million of current receivables. We expect to generate unlevered IRR of greater than 25%. The second portfolio that we purchased in partnership with Pathway Capital using leverage is performing in line with our expectations. The debt associated with that purchase stood at $176 million and will be paid down rapidly as receivables are collected. We expect to have a levered IRR of over 40% on this portfolio. As the general lending environment tightens and market volatility and distress continue to accelerate, we are well positioned to deliver value to our clients, both in a capacity as a lender and as a strategic adviser to the company is navigating a restructuring and distressed situation. And while we are opportunistic, we remain diligent about our capital allocation and assessing the various opportunities being presented by the current dislocation of markets. For example, we participate in Bluestar Alliance’s recent acquisition of Scotch & Soda, which is a men’s clothing brand. This investment builds on the success of our longstanding relationship with Bluestar and enhances our existing brands business, which has generated meaningful returns for us since its inception on our platform in late 2019. Similar to our prior co-investments with Bluestar, which included the Hurley brand, the Justice brand and our Six brands portfolio, Bluestar will continue to operate the Scotch & Soda brand while expanding its distribution strategy and introducing the brand of new consumer demographics. As we look ahead, we see many opportunities to capitalize on the dislocations being presented by the current market environment. We recognize and appreciate that our story becomes a little more complex as we further diversify our platform. However, we remain steadfast in our approach and in our commitment to deliver for our colleagues, clients, partners and shareholders. With that, I will turn the call over to Phil on, our CFO and COO, to discuss key financial metrics for the quarter. Our Co-CEO, Tom Kelleher, will discuss results from our business segments before we open for questions. Phil?